{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T01:00:28Z","timestamp":1772672428503,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-22831-4","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T13:53:40Z","timestamp":1762437220000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence and associated factors of hyperuricemia in chronic kidney disease: evidence from a single-center hospital-based study in Ethiopia, 2024"],"prefix":"10.1038","volume":"15","author":[{"given":"Agerye Kassa","family":"Yirdaw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1274-7383","authenticated-orcid":false,"given":"Yihealem Yabebal","family":"Ayele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailemaryam","family":"Alemu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsebaot","family":"Tesfaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Workagegnehu","family":"Hailu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desalew","family":"Getahun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"issue":"4 Suppl","key":"22831_CR1","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 105 (4 Suppl), S117\u2013S314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018 (2024).","journal-title":"Kidney Int."},{"issue":"7","key":"22831_CR2","doi-asserted-by":"publisher","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","volume":"11","author":"NR Hill","year":"2016","unstructured":"Hill, N. R. et al. Global prevalence of chronic kidney disease \u2013 a systematic review and meta-analysis. PLoS One. 11 (7), e0158765 (2016).","journal-title":"PLoS One"},{"issue":"9888","key":"22831_CR3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","volume":"382","author":"V Jha","year":"2013","unstructured":"Jha, V. et al. Chronic kidney disease: global dimension and perspectives. Lancet 382 (9888), 260\u2013272 (2013).","journal-title":"Lancet"},{"key":"22831_CR4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1471-2458-14-210","volume":"14","author":"A Misganaw","year":"2014","unstructured":"Misganaw, A. et al. Epidemiology of major non-communicable diseases in ethiopia: a systematic review. BMC Public. Health. 14, 210 (2014).","journal-title":"BMC Public. Health"},{"issue":"3","key":"22831_CR5","doi-asserted-by":"crossref","first-page":"e0282569","DOI":"10.1371\/journal.pone.0282569","volume":"18","author":"KT Gashaye","year":"2023","unstructured":"Gashaye, K. T., Ayenew, A. B. & Mekonen, T. E. Chronic kidney disease and associated factors among adult hypertensive patients at selected hospitals in Ethiopia. PLoS One. 18 (3), e0282569 (2023).","journal-title":"PLoS One"},{"issue":"Special Issue","key":"22831_CR6","first-page":"55","volume":"34","author":"E Berhe","year":"2020","unstructured":"Berhe, E. et al. Challenges and gaps in kidney disease care in low-income countries: evidence from nephrology service provision in Ethiopia. Ethiop. J. Health Dev. 34 (Special Issue), 55\u201362 (2020).","journal-title":"Ethiop. J. Health Dev."},{"key":"22831_CR7","unstructured":"Alebachew, A. et al. Ethiopia Health Sector Assessment (USAID & Health Finance and Governance Project, 2016)."},{"issue":"1","key":"22831_CR8","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12882-022-02901-9","volume":"23","author":"Y Tadesse","year":"2022","unstructured":"Tadesse, Y., Solomon, S. & Hailu, A. Knowledge, attitude, and practices of traditional medicine use among CKD patients in addis Ababa, Ethiopia. BMC Nephrol. 23 (1), 278 (2022).","journal-title":"BMC Nephrol."},{"issue":"2","key":"22831_CR9","first-page":"194","volume":"28","author":"BI Freedman","year":"2019","unstructured":"Freedman, B. I. & Limou, S. Genetic factors in chronic kidney disease: APOL1 and beyond. Curr. Opin. Nephrol. Hypertens. 28 (2), 194\u2013200 (2019).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"3","key":"22831_CR10","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.kint.2018.05.009","volume":"94","author":"V Jha","year":"2018","unstructured":"Jha, V. & Modi, G. K. Getting to know the enemy better \u2013 the global burden of chronic kidney disease. Kidney Int. 94 (3), 462\u2013464 (2018).","journal-title":"Kidney Int."},{"issue":"5","key":"22831_CR11","first-page":"925","volume":"62","author":"RJ Johnson","year":"2013","unstructured":"Johnson, R. J. et al. Uric acid and chronic kidney disease: which is chasing which? Am. J. Kidney Dis. 62 (5), 925\u2013931 (2013).","journal-title":"Am. J. Kidney Dis."},{"issue":"17","key":"22831_CR12","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMra0800885","volume":"359","author":"DI Feig","year":"2008","unstructured":"Feig, D. I., Kang, D. H. & Johnson, R. J. Uric acid and cardiovascular risk. N Engl. J. Med. 359 (17), 1811\u20131821 (2008).","journal-title":"N Engl. J. Med."},{"issue":"1","key":"22831_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette, P. et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann. Rheum. Dis. 76 (1), 29\u201342 (2017).","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"22831_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa1515920","volume":"375","author":"C Wanner","year":"2016","unstructured":"Wanner, C. et al. Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl. J. Med. 375 (4), 323\u2013334 (2016).","journal-title":"N Engl. J. Med."},{"issue":"13","key":"22831_CR15","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1056\/NEJMoa1710895","volume":"378","author":"WB White","year":"2018","unstructured":"White, W. B. et al. Cardiovascular safety of febuxostat or allopurinol in patients with gout. N Engl. J. Med. 378 (13), 1200\u20131210 (2018).","journal-title":"N Engl. J. Med."},{"issue":"10","key":"22831_CR16","first-page":"e040759","volume":"10","author":"M Yoshida","year":"2020","unstructured":"Yoshida, M. et al. Clinical characteristics of hyperuricemia in patients with chronic kidney disease: results from the J-CKD-DB study. BMJ Open. 10 (10), e040759 (2020).","journal-title":"BMJ Open."},{"key":"22831_CR17","first-page":"134","volume":"3","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Prevalence of hyperuricemia in chronic kidney disease: a systematic review and meta-analysis. Explor. Med. 3, 134\u2013145 (2022).","journal-title":"Explor. Med."},{"issue":"10","key":"22831_CR18","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1002\/art.30520","volume":"63","author":"Y Zhu","year":"2011","unstructured":"Zhu, Y., Pandya, B. J. & Choi, H. K. Prevalence of gout and hyperuricemia in the US general population: NHANES 2007\u20132008. Arthritis Rheum. 63 (10), 3136\u20133141 (2011).","journal-title":"Arthritis Rheum."},{"issue":"7","key":"22831_CR19","first-page":"515","volume":"17","author":"E Russo","year":"2015","unstructured":"Russo, E., Viazzi, F. & Pontremoli, R. Hyperuricemia and renal function decline: mechanisms and clinical implications. J. Clin. Hypertens. 17 (7), 515\u2013521 (2015).","journal-title":"J. Clin. Hypertens."},{"key":"22831_CR20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12882-015-0044-2","volume":"16","author":"MP Halle","year":"2015","unstructured":"Halle, M. P., Takongue, J. E., Kengne, A. P., Kaze, F. F. & Takongmo, S. Serum uric acid levels and prevalence of hyperuricemia in the Cameroonian adult population: a cross-sectional study. BMC Nephrol. 16, 125 (2015).","journal-title":"BMC Nephrol."},{"issue":"4","key":"22831_CR21","first-page":"278","volume":"11","author":"N Hashemi Madani","year":"2017","unstructured":"Hashemi Madani, N., Mohammadipour, N., Mahmoodi, M. R. & Hedayati, M. Hyperuricemia in non-alcoholic fatty liver disease with chronic kidney disease: an Iranian study. Iran. J. Kidney Dis. 11 (4), 278\u2013284 (2017).","journal-title":"Iran. J. Kidney Dis."},{"issue":"1","key":"22831_CR22","first-page":"58","volume":"23","author":"UH Okafor","year":"2020","unstructured":"Okafor, U. H. et al. Prevalence and clinical correlates of hyperuricaemia among Nigerians with chronic kidney disease. Niger J. Clin. Pract. 23 (1), 58\u201363 (2020).","journal-title":"Niger J. Clin. Pract."},{"issue":"2","key":"22831_CR23","first-page":"322","volume":"30","author":"A Mahamat","year":"2019","unstructured":"Mahamat, A. et al. Hyperuricemia in patients with chronic kidney disease in Chad. Saudi J. Kidney Dis. Transpl. 30 (2), 322\u2013327 (2019).","journal-title":"Saudi J. Kidney Dis. Transpl."},{"issue":"4 Suppl)\\","key":"22831_CR24","first-page":"S1","volume":"99","author":"KDIGO Anemia Work Group","year":"2021","unstructured":"KDIGO Anemia Work Group. KDIGO 2021 clinical practice guideline for the management of anemia in chronic kidney disease. Kidney Int. 99 (4 Suppl)\\), S1\u2013S87 (2021).","journal-title":"Kidney Int."},{"key":"22831_CR25","unstructured":"Kumar, P. & Clark, M. Clinical Medicine 9th edn p. 389 (Elsevier Saunders, 2017)."},{"issue":"5","key":"22831_CR26","first-page":"850","volume":"62","author":"National Kidney Foundation","year":"2013","unstructured":"National Kidney Foundation. KDOQI clinical practice guideline for proteinuria and albuminuria in chronic kidney disease: 2013 update. Am. J. Kidney Dis. 62 (5), 850\u2013886 (2013).","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"22831_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","volume":"24","author":"DE Morisky","year":"1986","unstructured":"Morisky, D. E., Green, L. W. & Levine, D. M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med. Care. 24 (1), 67\u201374 (1986).","journal-title":"Med. Care"},{"key":"22831_CR28","unstructured":"World Health Organization. AUDIT: the Alcohol Use Disorders Identification Test \u2013 Guidelines for Use in Primary Care 2nd edn (WHO, 2001)."},{"issue":"9","key":"22831_CR29","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1007\/s11606-011-1689-6","volume":"26","author":"F Hill-Briggs","year":"2011","unstructured":"Hill-Briggs, F. et al. Effect of problem-solving-based diabetes self-management training on diabetes control in a low-income patient sample. J. Gen. Intern. Med. 26 (9), 972\u2013978 (2011).","journal-title":"J. Gen. Intern. Med."},{"key":"22831_CR30","unstructured":"World Health Organization. Global Recommendations on Physical Activity for Health (WHO, 2010)."},{"issue":"25","key":"22831_CR31","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"Expert Panel on","year":"2002","unstructured":"Expert Panel on. Detection, Evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the NCEP adult treatment panel III (ATP III). Circulation 106 (25), 3143\u20133421 (2002).","journal-title":"Circulation"},{"issue":"6","key":"22831_CR32","doi-asserted-by":"publisher","first-page":"030006052091922","DOI":"10.1177\/0300060520919224","volume":"48","author":"LP Guo","year":"2020","unstructured":"Guo, L. P. et al. A retrospective cross-sectional study of the associated factors of hyperuricemia in patients with chronic kidney disease. J. Int. Med. Res. 48 (6), 0300060520919224. https:\/\/doi.org\/10.1177\/0300060520919224 (2020).","journal-title":"J. Int. Med. Res."},{"issue":"1","key":"22831_CR33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12882-020-01761-5","volume":"21","author":"JY Duan","year":"2020","unstructured":"Duan, J. Y. et al. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in a central Chinese urban population: a cross-sectional survey. BMC Nephrol. 21 (1), 115. https:\/\/doi.org\/10.1186\/s12882-020-01761-5 (2020).","journal-title":"BMC Nephrol."},{"issue":"6","key":"22831_CR34","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1291\/hypres.28.537","volume":"28","author":"F Viazzi","year":"2005","unstructured":"Viazzi, F. et al. Serum uric acid and target organ damage in primary hypertension. Hypertens. Res. 28 (6), 537\u2013543 (2005).","journal-title":"Hypertens. Res."},{"issue":"1","key":"22831_CR35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12882-017-0699-y","volume":"18","author":"FF Kaze","year":"2017","unstructured":"Kaze, F. F. et al. Pattern and correlates of uric acid levels in adult Cameroonians with non-dialysis CKD. BMC Nephrol. 18 (1), 283 (2017).","journal-title":"BMC Nephrol."},{"issue":"6","key":"22831_CR36","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0026-0495(99)90168-8","volume":"48","author":"H Sumino","year":"1999","unstructured":"Sumino, H. et al. Effects of aging and postmenopausal hypoestrogenism on serum uric acid levels. Metabolism 48 (6), 693\u2013697. https:\/\/doi.org\/10.1016\/S0026-0495(99)90168-8 (1999).","journal-title":"Metabolism"},{"issue":"9","key":"22831_CR37","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1093\/ndt\/gft029","volume":"28","author":"RJ Johnson","year":"2013","unstructured":"Johnson, R. J. et al. Uric acid and chronic kidney disease: which is chasing which? Nephrol. Dial Transpl. 28 (9), 2221\u20132228. https:\/\/doi.org\/10.1093\/ndt\/gft029 (2013).","journal-title":"Nephrol. Dial Transpl."},{"issue":"6887","key":"22831_CR38","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/417447a","volume":"417","author":"A Enomoto","year":"2002","unstructured":"Enomoto, A. et al. Molecular identification of a renal urate\u2013anion exchanger that regulates blood urate levels. Nature 417 (6887), 447\u2013452. https:\/\/doi.org\/10.1038\/417447a (2002).","journal-title":"Nature"},{"issue":"11","key":"22831_CR39","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/hr.2015.76","volume":"38","author":"E Kanda","year":"2015","unstructured":"Kanda, E., Muneyuki, T., Suwa, K., Nakajima, K. & Iimuro, S. Impact of proteinuria on uric acid metabolism and its relationship with cardiovascular risk factors in patients with chronic kidney disease. Hypertens. Res. 38 (11), 835\u2013840. https:\/\/doi.org\/10.1038\/hr.2015.76 (2015).","journal-title":"Hypertens. Res."},{"issue":"2","key":"22831_CR40","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1253\/circj.CJ-12-0862","volume":"77","author":"M Kuwabara","year":"2013","unstructured":"Kuwabara, M. et al. Hyperuricemia is an independent risk factor for atrial fibrillation in a Japanese health screening population. Circ. J. 77 (2), 447\u2013453. https:\/\/doi.org\/10.1253\/circj.CJ-12-0862 (2013).","journal-title":"Circ. J."},{"issue":"8","key":"22831_CR41","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0026-0495(98)90274-6","volume":"47","author":"F Matsuura","year":"1998","unstructured":"Matsuura, F. et al. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism 47 (8), 929\u2013933. https:\/\/doi.org\/10.1016\/S0026-0495(98)90274-6 (1998).","journal-title":"Metabolism"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22831-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22831-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22831-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T13:53:44Z","timestamp":1762437224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22831-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22831"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-22831-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted according to the declaration of Helsinki. Formal ethical clearance was obtained from the Institutional Review Board (IRB) of College of Medicine and Health Sciences, University of Gondar, protocol number (565\/2015). Informed written consent was taken from all participants and patient data confidentiality was respected at all levels, including chart retrieving and data analysis, which was handled by the investigators.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical considerations"}}],"article-number":"38938"}}